0001193125-26-224428
SEC filingQ1 losses narrowed through reduced R&D resources amid revenue declines from macroeconomic pressures, but acute liquidity constraints with low cash and negative working capital raise substantial going concern risks.
Longevity Health Holdings Inc. reported Q1 FY2026 results reflecting ongoing challenges in a volatile macroeconomic environment. Revenue fell 23.2% year-over-year to $391.8K from $510.4K, as government trade tensions, commodity price volatility, supply chain interruptions, inflation, and fluctuating interest rates disrupted markets. This decline pressured topline growth despite efforts to navigate these headwinds.
Gross profit decreased 12.2% to $237.0K from $269.8K, yet gross margin expanded to 60.5%, indicating relatively stable cost dynamics relative to revenue contraction. The shallower drop in gross profit compared to revenue underscores some resilience in pricing or input efficiencies amid broader demand softness.